QuidelOrtho Corporation
QDEL
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids forā¦ read more
Healthcare
Medical Instruments & Supplies
35 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$16.77
Price+1.21%
$0.20
1Y
Price
Market Cap
$1.144b
Small
Price/Earnings 3y Avg5y Avg
12.5x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-85.5%
EBITDA Margin-104.7%
Net Profit Margin-13.5%
Free Cash Flow Margin-85.5%
EBITDA Margin-104.7%
Net Profit Margin-13.5%
Free Cash Flow MarginRevenue
$2.657b
-2.4%
1y CAGR-5.9%
3y CAGR+18.6%
5y CAGREarnings
-$1.211b
+42.5%
1y CAGR-6758.7%
3y CAGR-5074.6%
5y CAGREPS
-$17.85
+44.3%
1y CAGR-6772.4%
3y CAGR-5089.8%
5y CAGRBook Value
$1.851b
$5.629b
Assets$3.777b
Liabilities$2.875b
DebtDebt to Assets
51.1%
-5.5x
Debt to EBITDAFree Cash Flow
-$75.200m
+61.8%
1y CAGR-95.6%
3y CAGR-60.4%
5y CAGRNo items found.
Press Releases
Statements and updates from the company